MX2015017413A - Metodos para analizar composiciones de cisteamina. - Google Patents

Metodos para analizar composiciones de cisteamina.

Info

Publication number
MX2015017413A
MX2015017413A MX2015017413A MX2015017413A MX2015017413A MX 2015017413 A MX2015017413 A MX 2015017413A MX 2015017413 A MX2015017413 A MX 2015017413A MX 2015017413 A MX2015017413 A MX 2015017413A MX 2015017413 A MX2015017413 A MX 2015017413A
Authority
MX
Mexico
Prior art keywords
methods
analyzing
cysteamine
compositions
cysteamine compositions
Prior art date
Application number
MX2015017413A
Other languages
English (en)
Other versions
MX370192B (es
Inventor
Kathlene Powell
Ramesh Muttavarapu
Original Assignee
Raptor Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Raptor Pharmaceuticals Inc filed Critical Raptor Pharmaceuticals Inc
Publication of MX2015017413A publication Critical patent/MX2015017413A/es
Publication of MX370192B publication Critical patent/MX370192B/es

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/62—Detectors specially adapted therefor
    • G01N30/74—Optical detectors
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/32—Bonded phase chromatography
    • B01D15/325—Reversed phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N21/25—Colour; Spectral properties, i.e. comparison of effect of material on the light at two or more different wavelengths or wavelength bands
    • G01N21/31—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry
    • G01N21/33—Investigating relative effect of material at wavelengths characteristic of specific elements or molecules, e.g. atomic absorption spectrometry using ultraviolet light
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/06—Preparation
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/04—Preparation or injection of sample to be analysed
    • G01N30/16—Injection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/15—Medicinal preparations ; Physical properties thereof, e.g. dissolubility
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N2030/022—Column chromatography characterised by the kind of separation mechanism
    • G01N2030/027—Liquid chromatography
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/88—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8818—Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02—Column chromatography
    • G01N30/26—Conditioning of the fluid carrier; Flow patterns
    • G01N30/28—Control of physical parameters of the fluid carrier
    • G01N30/34—Control of physical parameters of the fluid carrier of fluid composition, e.g. gradient
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/17—Nitrogen containing
    • Y10T436/173845—Amine and quaternary ammonium

Landscapes

  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describen métodos de análisis de la pureza de composiciones que comprenden cisteamina y detección de impurezas en composiciones de cisteamina.
MX2015017413A 2013-06-17 2014-06-17 Metodos para analizar composiciones de cisteamina. MX370192B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361835987P 2013-06-17 2013-06-17
PCT/US2014/042616 WO2014204887A1 (en) 2013-06-17 2014-06-17 Methods for analyzing cysteamine compositions

Publications (2)

Publication Number Publication Date
MX2015017413A true MX2015017413A (es) 2016-06-21
MX370192B MX370192B (es) 2019-12-04

Family

ID=52105169

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015017413A MX370192B (es) 2013-06-17 2014-06-17 Metodos para analizar composiciones de cisteamina.

Country Status (12)

Country Link
US (3) US9435785B2 (es)
EP (1) EP3011312B8 (es)
JP (1) JP6518658B2 (es)
AR (1) AR096629A1 (es)
CA (1) CA2914674C (es)
ES (1) ES2931310T3 (es)
HK (1) HK1224012A1 (es)
IL (1) IL242843B (es)
MX (1) MX370192B (es)
PL (1) PL3011312T3 (es)
TW (1) TWI659209B (es)
WO (1) WO2014204887A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109633055B (zh) * 2018-12-29 2023-01-13 贵州长生药业有限责任公司 杀菌止痒洗剂多成分含量测定方法
US11782040B1 (en) * 2023-05-12 2023-10-10 Michele Glinn Cannabis potency testing method

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6050186B2 (ja) * 1980-07-15 1985-11-07 三井東圧化学株式会社 ２−メルカプトエチルアミンハロゲン化水素酸塩類の製造法
US5011608A (en) * 1988-11-18 1991-04-30 Dragana Damjanovic Biogenic amine assay using HPLC-ECD
US5256362A (en) * 1989-07-14 1993-10-26 Nippon Shokubai Co., Ltd. Method for production of granular cysteamine hydrochloride
WO1997014711A1 (en) * 1995-10-19 1997-04-24 Receptagen Corporation Vitamin b12 receptor modulating agents and methods related thereto
JP3523207B2 (ja) * 2000-02-14 2004-04-26 ファイザー・プロダクツ・インク ＲＰ−ＨＰＬＣカラムを介してのＬｏｇＰ係数の測定
PT1531794T (pt) * 2002-06-28 2017-09-14 Civitas Therapeutics Inc Epinefrina inalável
US20050250838A1 (en) * 2004-05-04 2005-11-10 Challapalli Prasad V Formulation for sustained delivery
EP1893632B1 (en) * 2005-06-17 2015-08-12 Novo Nordisk Health Care AG Selective reduction and derivatization of engineered factor vii proteins comprising at least one non-native cysteine
WO2007089670A2 (en) * 2006-01-27 2007-08-09 The Regents Of The University Of California Enterically coated cysteamine, cystamine and derivatives thereof
WO2007092331A2 (en) * 2006-02-02 2007-08-16 Esa Biosciences, Inc. Detection methods and devices
SG138487A1 (en) * 2006-06-19 2008-01-28 Singapore Polytechnic Method for catalysing a fusion polypeptide undergoing a cleavage reaction
US20080103169A1 (en) * 2006-10-27 2008-05-01 The Curators Of The University Of Missouri Compositions comprising acid labile proton pump inhibiting agents, at least one other pharmaceutically active agent and methods of using same
SG176525A1 (en) * 2006-12-22 2011-12-29 Sigma Tau Ind Farmaceuti Gel useful for the delivery of ophthalmic drugs
US20080206883A1 (en) 2007-02-26 2008-08-28 Cody Laboratories, Inc. Hplc method for separation and detection of hydromorphone and related opioid pharmacophores
JP2010133807A (ja) * 2008-12-03 2010-06-17 Dainippon Sumitomo Pharma Co Ltd 錠剤の粉砕方法およびこれをもちいた錠剤成分の分析方法
PT2464655T (pt) * 2009-08-11 2017-05-25 Biocon Ltd Processos cromatográficos
CA2732440C (en) * 2011-02-23 2017-10-31 Universite Laval Cystamine analogues for the treatment of parkinson`s disease
CN103018359B (zh) 2012-11-30 2014-06-11 华南理工大学 一种测定食品或蔬菜中草酸含量的方法
AR096628A1 (es) * 2013-06-17 2016-01-20 Raptor Pharmaceuticals Inc Formulación en perlas de cisteamina de liberación retardada y métodos de preparación y uso de ella

Also Published As

Publication number Publication date
US9435785B2 (en) 2016-09-06
HK1224012A1 (zh) 2017-08-11
JP2016523364A (ja) 2016-08-08
JP6518658B2 (ja) 2019-05-22
EP3011312B8 (en) 2022-11-02
TW201534920A (zh) 2015-09-16
PL3011312T3 (pl) 2023-04-11
EP3011312B1 (en) 2022-09-28
MX370192B (es) 2019-12-04
EP3011312A1 (en) 2016-04-27
TWI659209B (zh) 2019-05-11
US20160341706A1 (en) 2016-11-24
CA2914674C (en) 2019-08-27
WO2014204887A1 (en) 2014-12-24
AR096629A1 (es) 2016-01-20
IL242843B (en) 2019-01-31
ES2931310T3 (es) 2022-12-28
CA2914674A1 (en) 2014-12-24
EP3011312A4 (en) 2017-01-25
US20180292366A1 (en) 2018-10-11
US20150056712A1 (en) 2015-02-26

Similar Documents

Publication Publication Date Title
IL289821B (en) Preparations and methods for immunotherapy
HK1220387A1 (zh) 用於免疫療法的組合物和方法
EP3013957A4 (en) COMPOSITIONS AND METHODS FOR SAMPLE PROCESSING
IL272171B (en) The compositions for the analysis of the interaction between RNA and chromatin, and their uses
IL240512B (en) Methods and preparations for sorting samples
IL285527A (en) Preparations and methods for immunotherapy
EP2948423A4 (en) EXTRUSION PROTECTION COMPOSITIONS FOR SEALANT AND WEAR COMPONENTS
IL245713A0 (en) A method for the detection and quantitative analysis by hplc of impurities in the product obtained in the preparation of dianhydrogalactitol
MX2015017413A (es) Metodos para analizar composiciones de cisteamina.
EP2956469A4 (en) METHODS AND COMPOSITIONS FOR CONCENTRATING PROTEINS
WO2015066439A8 (en) Methods of treating hematological malignancies
ZA201500493B (en) Glycoconjugation processes and compositions
GB201308949D0 (en) Compositions and methods for reducing methane production

Legal Events

Date Code Title Description
FG Grant or registration
HC Change of company name or juridical status

Owner name: CELGENE INTERNATIONAL II SARL